Company / Debt per Share
Haemonetics Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$24.54
FY2025
5-year range
$10.88 / $24.54
FY2021-FY2025
Trend
+55.2%
vs FY2024
Sector context
#28 of 100
Health Care
What the data says
At $24.54, Haemonetics's debt per share ranks #73 of 100 in the Health Care sector. Debt per Share has increased for 3 consecutive years, from $10.88 in FY2022 to $24.54 in FY2025.
Based on SEC 10-K filings.
24.54 in FY2025 with a 5-year CAGR of +32.7%.
Increased from $14.67 to $24.54 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +31.1%
- 5-Year CAGR
- +32.7%
- 10-Year CAGR
- -
Sector benchmark
#73 of 100 in Health CareTop 72% of 100This company $24.54 Sector average $45.62
▼
-46.2% below sector average
Key checks
Key Insights
- Haemonetics's debt per share has grown for 3 consecutive years.
- In FY2025, debt per share increased 55.2% year-over-year.
- Ranks #28 out of 100 companies in the Health Care sector.
- Lowest debt per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.54 | +55.2% |
| FY2024 | $15.81 | +7.8% |
| FY2023 | $14.67 | +34.9% |
| FY2022 | $10.88 | -19.1% |
| FY2021 | $13.45 | +125.8% |
| FY2020 | $5.96 | -4.3% |
| FY2019 | $6.22 | +447.3% |
| FY2018 | $1.14 | -81.7% |
| FY2017 | $6.20 | -21.6% |
| FY2016 | $7.91 | -4.4% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026